Stock Events

Stock Events

Aligos Therapeutics (ALGS) Q2 2026 Earnings

May 7Confirmed

Q2 2025

Q3 2025

Q4 2025

Q2 2026

-3.04

-2.54

-2.03

-1.53

Details

Expected EPS

-2.213262

Actual EPS

-2.21

Surprise EPS

0

Surprise Percent

+0.15%

Description

⁨Aligos Therapeutics⁩ (⁦ALGS⁩) has reported earnings of ⁦-2.21⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.